Abstract Background Medication errors (MEs) are common in health care settings and pose a threat for the hospitalized population. Therefore, aspects of MEs were explored in a tertiary setting serving a diverse population. Objective To examine the occurrence, severity and reporting of MEs in hospitalized patients. Methods This retrospective analysis included 10,683 ME report forms that were received by the Medication Safety Unit of King Saud Medical City (KSMC) in 2015. ME outcomes were determined according to the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) Index for categorizing MEs algorithm. Results A total of 13,677 MEs in 912,500 prescriptions were reported. The incidence rate of MEs was 1.5% (13,677/912,500). The highest percentage (42.2%) of MEs occurred during the transcription stage, and 70.0% of MEs were reported as near misses. Wrong frequency and wrong concentration accounted for nearly half of the MEs. Conclusion We found 1.5 MEs per 100 prescriptions; more than two-thirds of the MEs were preventable and were intercepted before reaching the patients. Most MEs reported by pharmacists occurred at the transcription stage while wrong frequency was the most common error type encountered. Further studies should explore the clinical consequences of MEs at a healthcare institution.
Introduction
A medication error (ME) is defined as ''any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional (HCP), patient, or consumer. Such events may be related to professional practice, healthcare products, procedures, and systems, including prescribing, order communication, product labelling, packaging, and nomenclature, compounding, dispensing, distribution, administration, education, monitoring, and use'' [1] .
The National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) developed the ME index to classify preventable errors according to the degree of patient harm and helps institutions and HCPs track MEs in a consistent and systemic manner [1] . The occurrence of MEs eventually may increase morbidity and mortality rates in the hospitalized population. Most preventable adverse Electronic supplementary material The online version of this article (doi:10.1007/s11096-017-0514-7) contains supplementary material, which is available to authorized users. drug events, which can occur during any stage of medication use, are associated with MEs. MEs have been reported to occur at rates of 5 and 36% in a tertiary care setting in the United States (US) and India, respectively. However, many MEs remain undetected when outcomes do not affect hospitalized patients [2] [3] [4] . Previous research in the Kingdom of Saudi Arabia (KSA) revealed that onethird of adverse drug reactions occurred due to MEs [5] .
Despite alarming figures cited by international patient safety organizations and the increasing literature in developed countries, there is a paucity of empirical evidence that is pertinent to the incidence and outcomes of MEs in the Kingdom of Saudi Arabia (KSA) and other Middle Eastern countries [6] . Although the impact of MEs on patient health status remains at the forefront globally, this lack of data is an obstacle to developing prevention strategies that minimize patient harm. The findings of this study will facilitate the development of prevention strategies, and aid in implementing awareness and educational programmes, thus improving the hospital medication use process and patient safety.
Aim of the study
This study aimed to investigate the incidence, nature, reporting and severity of MEs in a tertiary care setting.
Ethics approval
Approval was obtained from Institutional Review Board of King Saud Medical City (KSMC).
Methods
This study is a retrospective analysis of MEs reported by HCPs from January 2015 to December 2015 at KSMC, a large tertiary care Ministry of Health hospital in the KSA.
MEs reporting at KSMC is an anonymous process that is intended for use by HCPs. MEs are reported voluntarily to the Medication Safety Unit, which operates under the umbrella of pharmaceutical care services. The Medication Safety Unit is operated by three pharmacists, and their main activities are to review and analyse MEs, ensure the compliance of HCPs to medication safety policies and procedures, and improve patient safety and the medication use process. All HCPs report MEs to the Medication Safety Unit using a paper-based format called the ME report form. This study included 10,683 ME report forms, and more than one error was reported per form. The collected ME report forms were reviewed by the pharmacy designee in the Medi-cation Safety Unit, who also reviewed the patient's medical record and contacted the reporter if any information required clarification. NCC MERP Index for categorizing MEs algorithm was used to determine the severity of the MEs [1] .
The variables included in this study were cause of errors (this section was completed by the reporters based on their perception), type of errors, stage involved, error made/reported by, and outcome. The Medication Safety Unit also received forms lacking information for the outcome section; the ''unknown'' category was created to cover these cases, and the forms were not rejected. The data were analysed using the Statistical Package for the Social Sciences version 17. Descriptive statistics were used to calculate frequencies and percentages.
Results
In total, 13,677 MEs were reported by HCPs in 2015, and 912,500 prescriptions were ordered in the same year. The incidence rate of MEs was 1.5% (13,677/912,500). MEs occurred most frequently in the fourth quarter (OctoberDecember) with 36.1% of the total MEs, followed by the third, second, and first quarters with 26.7, 20.2, and 16.9% of the total MEs, respectively (see ''Supplementary Material''). Most errors occurred at the transcribing stage (42.28%), followed by errors occurring at the prescribing stage (27.53%); the fewest errors occurred at the dispensing and administration stages (7.1%). We also found missing data in the ME report forms. Wrong frequency and wrong drug strength/concentration were the most common types of errors and accounted for 27.8 and 21.1% of MEs, respectively (Table 1) .
Pharmacists detected and reported most MEs (82.52%) and made fewer errors (9.38%) than physicians (39.46%) and nurses (28.35%). Other HCPs reported only 0.55% of total MEs. The main ME causes reported were lack of staff education (67.47%), followed by miscommunication of drug orders (19.04%) and look-alike/sound-alike medication problems (7.54%). Of the 13,677 MEs reported, 70.5% corresponded to near misses, and a very small percentage of errors (0.04%) caused temporary harm to the patients (Table 2) .
Discussion
This study explored the aspects of ME reporting at a large tertiary care setting in the KSA. The incidence of MEs was found to be 1.5 per 100 prescriptions, consistent with earlier studies that reported an ME occurrence of 1.5-5.3 per 100 prescriptions [3, 7] .
This study shows that most of the errors were near misses and preventable, similar to the findings of a cohort study conducted in the KSA [5] . Adverse events associated with MEs can be prevented with the interception of errors before drug administration [8] . Similar to earlier reports, majority of the errors occurred at prescribing and transcribing stage of the medication use process while more than eighty percent of these errors were intercepted by pharmacists. Pharmacist interventions prevented MEs by 11-89% during the medication use process, and their role in patient safety has also been addressed in previously published reports [4, 5, 9] . The high reporting rate of MEs by pharmacists is due to the implementation of appreciation awards for pharmacists, an initiative developed by the pharmaceutical care services. Moreover, error rates gradually increased in the fourth quarter, which is certainly due to the announcement of the appreciation awards for pharmacists. The reporting rate of MEs by other HCPs was low which can be improved by promoting a culture of appreciation for physicians and nurses; this has been acknowledged by the Institute for Safe Medication Practices as being one of the best practices to increase the reporting of MEs [10] . Such initiatives will be crucial to tackle the under-reporting of MEs, which is prevalent in the KSA [11] . There is also a need to promote a non-punitive culture because earlier reports reported that the fear of disciplinary action and job termination promotes the under-reporting of MEs in healthcare settings [12] .
This study also found that the outcome section was not completed in some forms, whereas it is imperative to complete all sections of the ME report form. The most common cause, based on the perception of HCPs, was lack of knowledge. It is imperative to conduct educational and awareness sessions for HCPs regarding the importance of reporting MEs and medication safety policies and procedures, thereby improving patient safety and the ME reporting system [6] . Errors that occurred during the transcribing stage were frequently reported by HCPs, in contrast to earlier findings of studies conducted in the KSA and other settings [2, 5] . There is a scarcity of literature regarding transcribing errors in the Middle East, which renders comparison difficult [6] . However, these findings are consistent with those found in large tertiary care settings in Nordic countries, such as Sweden and Denmark [4, 13] . This study showed that nearly fifty percent of errors involved the wrong frequency and wrong strength/concentration of drugs, and these types of MEs have also been frequently reported in other healthcare settings in the Middle East [6] . The finding of the wrong drug strength/concentration was consistent with the results of previous studies, whereas better communication amongst HCPs can reduce wrong dose errors [2] . Most error types can be avoided by introducing barcode technology and computerized physician-order entry (CPOE) [4] . Although CPOE was available at our study setting, physicians provide CPOE access to nurses, and this practice may obstruct the prevention of MEs in healthcare settings.
This study had some limitations. ME reporting at KSMC is voluntary and is thus unlikely to be a true representation of all MEs. This study was conducted at a single tertiary care institution in the KSA, and its results cannot be generalized to the entire population. The total number of prescriptions was used as a denominator, leading to a lack of clinical relevance, and it is imperative to determine ME incidence in relation to patient admissions and hospital stay. Further research should be directed towards determining the extent and clinical consequences of MEs at a tertiary care setting in the Kingdom. The factors contributing to the low reporting of MEs may also be explored.
Conclusion
This study showed an occurrence of 1.5 MEs per 100 prescriptions, although most MEs did not reach the patients and were preventable. MEs frequently occurred at the transcription stage of the medication use process, and wrong frequency was the most common error type encountered. Pharmacists reported more MEs than other HCPs. There is a need to study factors that may affect the reporting of MEs by different health care providers and establish a non-punitive culture to improve the reporting of MEs. Further studies should focus on determining the extent and clinical consequences of MEs in a tertiary care setting.
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